An established, collaborative, global cell therapy CDMO.

Reduce timelines and costs. De-risk clinical trials. Get to patients faster.

Learn More
Setting the Stage for Successful Clinical Manufacturing

Download BioCentriq's new eBook!

Five chapters of actionable advice on how to ensure quality, improve patient access, and reduce the cost of manufacturing.

Learn how to assess GMP-readiness and save time and money. 

Request Your Copy Now!

An Established, Collaborative, Global Cell Therapy CDMO

BioCentriq is a full-service, collaborative cell therapy CDMO. We support all stages of process development and cell therapy manufacturing.

What sets us apart from other CDMOs is our approach which is highly collaborative, transparent and attentive.

From the very beginning, you and your team are invited on site and given the option to work alongside our team.

Our established, phase appropriate quality systems and newly constructed facilities are uniquely designed to support the needs of early-stage autologous and allogeneic drug products.

Importantly, we also have a track record of successfully manufacturing and releasing drug products for use in human trials. 

Are you advancing a product to clinic?  Learn how you can get there faster with our proprietary LEAPTM Advanced Therapy Platform which helps early-stage developers go from contract to clinic in as short as six months.

 

Learn More
Image

Get to know BioCentriq and experience the innovative, open, collaborative, highly attentive and pragmatic approach we bring to every project.

Download our Brochure
Image

What we do

Our goal is to advance cell therapy manufacturing to make life altering medicines and therapeutics more accessible to patients.

We work with small and medium-sized biotech companies who need process development, CMC support for an IND submission, or manufacturing supplies for use in clinical trials.

Image

How we do it

BioCentriq's process development and MS&T teams specialize in helping small and mid-size biotech optimize and scale their therapies for clinical manufacturing.

Our process is designed to be highly collaborative with opportunities for virtual and on-site participation. We also offer a rapid tech transfer that prioritizes speed to help you get to clinic faster.
Image

Who we work with

In addition to offering support to small and medium-sized biotech's, we offer workforce development, process development and cell therapy manufacturing support for big pharma.

We also lead technology application projects that explore and validate the potential impact when novel and emerging technologies are applied during the manufacturing process.

Image

What we do

Our goal is to advance the manufacturing of cell and gene therapies to make them more accessible to patients. Our clients are small and medium-sized biotech companies who are preparing for an IND submission or their Phase 1 industry-sponsored clinical trial.

We also have clients who manufactured their Phase 1 or Phase 2 material elsewhere and because of our expertise, transferred their technology to BioCentriq to manufacture supplies for their upcoming Phase 2 or Phase 3 trial.

Read More
Image

How we do it

Our process development and MSAT (Manufacturing Science and Technology) teams specialize in helping small and mid-size biotech optimize and scale their cell and gene therapies for clinical manufacturing.

Our tech transfer process is also designed to be highly collaborative for client teams who want to join us on site at every stage. Our facilities, infrastructure, people, quality systems and regulatory services are prepared to support commercial manufacturing.
Read More
Image

Who we work with

We also work with big pharma and technology developers on workforce development programs that support the cell and gene industry as well as technology application projects that explore the potential impact when novel and emerging technologies are applied during the manufacturing process. Lastly, on behalf of McKinsey & Partners, we operate the only Digital Capability Center focused on life sciences.
Read More

    Why BioCentriq

    Image
    Proven Track Record in Cell Therapy Manufacturing
    Image
    Deep Expertise in Process Development, AMD and MS&T
    Image
    Newly Constructed, Flexible, and Modern GMP Facilities
    Image

    Phase-Appropriate Established Quality Systems

    Image

    LEAPTM  Platform for NK, CAR/TCR, T-Cell and Exosome Candidates

    Image
    Highly Skilled and Experienced Teams on Every Project
    Image

    Access to Novel Development and Manufacturing Technologies

    Image
    Technology and Manufacturing Equipment Agnostic
    Image
    Established, Resilient and Robust Supply Chain
    Image
    In-house QC Labs for In-Process and Release Testing

    Latest Updates

    From ISCT 2024: Watch Chathuranga De Silva, Ph.D., highlight BioCentriq’s achievements and LEAP™ Platform

    Watch Webinar On-Demand: End-to-End Automated Manufacturing of Low-Seed CAR-T Cells

    Watch 2024 Outsourced Pharma – BioCentriq Capabilities and Capacity Update Overview with Chat De Silva, Ph.D., Executive Director of Business Development

    Watch Webinar On-Demand: End-to-End Automated Manufacturing of Low-Seed CAR-T Cells

    Watch 2024 Outsourced Pharma – BioCentriq Capabilities and Capacity Update Overview with Chat De Silva, Ph.D., Executive Director of Business Development

    Biotech Banter Podcast, Episode 2: Quality Management Systems: Implementation Strategies And Compliance

    BioCentriq in the News

    SEE MORE

    Upcoming Events

    SEE ALL EVENTS

    Join Our Team

    We are looking for passionate and driven individuals with a background in cell therapy to join our growing team. If you thrive in a fast-paced, always evolving environment and embrace the mission of making cell therapies accessible to the patients who need them, we want to hear from you! Please browse our current job listings or contact our HR team.

    SEE ALL LISTINGS

    Get In Touch

    • This field is for validation purposes and should be left unchanged.